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 It has been described that fullerenes (C60) present interesting properties with potential 
application in clinical conditions related to oxidative stress.1
 One of the most prominent features of fullerenes is the ability to quench free radicals. 
 However, because of its poor solubility, this has been studied mostly in organic solutions, 
while the antioxidant activity and cytotoxicity of fullerenes and their derivates in aqueous 
medium is not well characterized 1. 
 The antioxidant capacity of synthesised C60-conjugates has been investigated and its was 
higher comparing to C60 isolated.  
 The aim of this study was to assess the viability of C60-conjugates by determining its 
antioxidant activity and cytotoxicity in bio-relevant media
INTRODUCTION EVALUATION OF LIPID PEROXIDATION (TBARS ASSAY)
• C60-MLV showed better antioxidant activity than C60-aq suspensions.
• C60BHT2-MLV was the most efficient against lipid peroxidation (less 40% in TBARS).
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Fig. 2– TBARS value (malondialdehyde (MDA) concentration) after MDA-TBA reaction  in the presence of fullerenes.
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 SOLUBILIZATION AND ENCAPSULATION OF C60 AND C60-BHTCONJUGATES
I. Fullerene (C60) and C60-Butylated hydroxytoluene conjugates (C60 -BHT1, C60-BHT2 and C60-
BHT3) 2 were  solubilized either through:
A. Surfactants addition (Polyvinylpyrrolidone (PVP) or Tween20 ); 3
B. Encapsulation in  liposomes, type multilamellar vesicles 
layers (MLV’s), suitable for pharmaceutical formulation; 4
C. Suspension in water. 3
II. Antioxidant activity was assessed by oxygen radical absorbance 
capacity (ORAC) 5 and by the assay of  thiobarbituric acid 
reactive substances (TBARS) 6. 
III. Biologic tests consisted in cytotoxicity assay 7 and intracellular 
antioxidant activity 8 , using Caco-2 cell lines.
MATERIAL AND METHODS
RESULTS
 EVALUATION OF CYTOTOXICITY TO CELLS (MTS ASSAY)
• None of the tested compounds revealed citotoxicity for up to 2.75 µM.
 EVALUATION OF INTRACELLULAR ANTIOXIDANT CAPACITY (CAA ASSAY)
• Both C60BHT3–MLV and C60-PVP have high intracellular antioxidant capacity, better 
then BHT.
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Fig. 3 – Cell viability after 4 hours 
contact with tested compounds, 
assessed by tetrazolium compound 
(MTS) bioreduction. Citotoxicity would 
be considered if the percentage of 
viable cells decreased below 80%, 
relative to controls, in the presence of 
the tested compound.
MLV PVP
Compounds %ROS CV (%)
%ROS Surfactant
- %ROS
%ROS CV (%)
%ROS Surfactant
- %ROS
C60 95.6 3.7 10.0 61.2 3.4 12.0
C60BHT1 89.7 1.4 15.8 66.4 3.2 6.8
C60BHT2 88.0 8.7 17.5 62.9 7.4 10.3
C60BHT3 78.6 4.0 26.9 63.1 9.0 10.1
BHT 88.9 5.2 16.6 63.8 1.3 9.4
MLV/PVP 105.5 7.1 0.0 73.2 4.9 0.0
Table 2 -Antioxidant activity of 2.75 µM C60 and C60 -BHT conjugates in liposomes (MLV) and in PVP. CV 
= coefficient of variation, n=3. 
Fig. 1– Fullerene compounds used in this study: 
1 - C60-BHT2; 3 - C60-BHT1; 4 - C60-BHT3 
(C60-BHT conjugates were synthesized by Enes R. et al 
2. 
BHT (Butylhydroxytoluene, a phenolic antioxidant) was used as a control.
• Fullerenes were successfully solubilized. The presence of C60 and C60-BHT conjugates in
micellar solutions was confirmed in a concentration of 27,5 µM.
 EVALUATION OF ANTIOXIDANT CAPACITY (ORAC ASSAY)
• C60BHT2-MLV and C60BHT1-PVP were the most efficient in the inhibition of free radical
damage(6,3% in relative ORAC level) .
Frel = (F60min-F0min)/ F0min (Eq. 2);              % ROS = (Frel sample/Frel control) x 100 (Eq. 3)  
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Table 1. Relative ORAC value (Eq. 1) for solubilized C60, C60BHT1, C60BHT2 and C60BHT3, at the concentration
of 2.75 µM. CV = coefficient of variation, n=3. 
C60 C60BHT1 C60BHT2 C60BHT3 BHT
MLV
5.2 
(7.9%)
4.9
(3.9%)
6.3 
(6.4%)
2.5 
(15.0%)
2.9 
(26.6%)
PVP
5.07 
(0.30 %)
6.3
(2.8%)
5.1
(9.6%)
5.0 
(4.5%)
6.3
(4.3%)
relative ORAC value = [(AUCSample- AUCBlank) / ( AUCTrolox - AUCBlank)] x (molarityTrolox/ molaritysample) (Eq. 1 )
 The problem of fullerenes poor solubility  was solved.  After homogeneous dissolution in 
biorelevant media, we were able to assess their antioxidant activity and cytotoxicity. The 
obtained results were strongly dependent on the solubilization system. 
 Encapsulated fullerenes (C60BHT2-MLV) showed the highest antioxidant activity, even better 
than BHT. 
 The biological tests revealed that fullerenes and their conjugates are not toxic in a 
concentration of 2.75 µM. 
 Some compounds were able to reduce intracellular activity of ROS to a lower level than BHT. 
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